Product Synopsis     

Global Data has released its pharma report, Pharma Point: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing RSV Market. The report identifies and analyses the key companies shaping and driving the global RSV market.

For More Information, Visit:

The report provides insight into the competitive RSV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.


  • Investigation of current and future market competition for RSV
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the RSV sector through market impact analysis, future market scenario and company analysis

Reasons to buy:

  • Gain a high level view of the trends shaping and driving the RSV Market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • Whats the next big thing in the global RSV market landscape? Identify, understand and capitalize

Category: Main topic classifications

1 Table of Contents

1 Table of Contents 7

1.1 List of Tables 9

1.2 List of Figures 9

2 Introduction 10

2.1 Catalyst 10

3 Market Outlook 11

3.1 US 11

3.1.1 Forecast 11

3.1.2 Key Events 13

3.1.3 Drivers and Barriers Global Issues 13

Click Here To Download Detail Report:

4 Current and Future Players 18

4.1 Overview 18

4.2 Trends in Corporate Strategy 19

4.3 Company Profiles 21

4.3.1 AstraZeneca (MedImmune) 21

4.3.2 Novavax 23

5 Appendix 26

5.1 Bibliography 26

5.2 Abbreviations 27

5.3 Methodology 28

5.4 Forecasting Methodology 28

5.4.1 Number of eligible patients for prophylaxis 28

5.4.2 Utilization rates of Synagis 29

5.4.3 Patient share and generic erosion 30

5.4.4 Weight of high risk infants 30

5.4.5 Cost per day 30

5.4.6 Number of prophylaxis days per year 30

5.4.7 Annual cost of therapy 31

5.4.8 Patient compliance 31

5.4.9 Total sales 31

5.4.10 Drugs Included in Each Therapeutic Class 31

5.4.11 Launch and Patent Expiry Dates 31

5.4.12 General Pricing Assumptions 32

5.4.13 Individual Drug Assumptions 32

5.5 Physicians and Specialists Included in this Study 33

5.6 About the Authors 34

5.6.1 Authors 34

5.6.2 Epidemiologist 35

5.6.3 Global Head of Healthcare 35

5.7 About GlobalData 36

5.8 Contact Us 36

5.9 Disclaimer 36

All Reports Of This Publisher:

About Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Web: AcuteMarketReports